Schedule 13G ownership disclosure

Abeona Therapeutics Inc

Common Stock, $0.01 par value · CUSIP: 00289Y206

Event date: 2026-03-26

Filing-level shares
2,943,629.00
Percent of class
5.16%
  • Daniel Kaufman

    Shares: 2,943,629.00 · Class: 5.16%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001099910-26-000139
Form type
SCHEDULE 13G
Filer
ABEONA THERAPEUTICS INC.
CIK
CIK 318306
Filed
Mar 27, 2026
Reporting period
Mar 26, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub